[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@ForFairnessSake "A quick look at Dayforces $DAY fairness opinion associated with acquisition by Thoma Bravo for $XXXX billion"
X Link @ForFairnessSake 2025-09-19T14:16Z XX followers, XX engagements

"Novo Nordisk to acquire Akero Therapeutics $AKRO for up to $5.2B. Structured with an upfront payment of $4.7B in cash ($54/share) a XX% premium to $AKRO 30-day VWAP. Also includes a $6/share CVR dependent upon full U.S. regulatory approval of efruxifermin (EFX) by June XX 2031"
X Link @ForFairnessSake 2025-10-09T20:57Z XX followers, XX engagements